Tower Research Capital (TRC)’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9K Buy
17,594
+8,276
+89% +$9.35K ﹤0.01% 3683
2025
Q1
$13.6K Sell
9,318
-20
-0.2% -$29 ﹤0.01% 3343
2024
Q4
$19.9K Buy
9,338
+3,963
+74% +$8.44K ﹤0.01% 3186
2024
Q3
$15.1K Sell
5,375
-26,210
-83% -$73.4K ﹤0.01% 3424
2024
Q2
$73.6K Buy
31,585
+25,513
+420% +$59.4K ﹤0.01% 2811
2024
Q1
$27.1K Sell
6,072
-51,725
-89% -$231K ﹤0.01% 2732
2023
Q4
$186K Buy
57,797
+49,548
+601% +$159K ﹤0.01% 2170
2023
Q3
$26.1K Sell
8,249
-5,385
-39% -$17.1K ﹤0.01% 3137
2023
Q2
$67.8K Buy
13,634
+5,200
+62% +$25.8K ﹤0.01% 2313
2023
Q1
$42K Sell
8,434
-8,020
-49% -$39.9K ﹤0.01% 2650
2022
Q4
$104K Sell
16,454
-10,824
-40% -$68.4K ﹤0.01% 1804
2022
Q3
$295K Buy
27,278
+8,851
+48% +$95.7K ﹤0.01% 1562
2022
Q2
$210K Sell
18,427
-8,238
-31% -$93.9K ﹤0.01% 1739
2022
Q1
$243K Buy
26,665
+11,859
+80% +$108K ﹤0.01% 1592
2021
Q4
$221K Buy
14,806
+2,499
+20% +$37.3K ﹤0.01% 1690
2021
Q3
$316K Buy
12,307
+6,077
+98% +$156K 0.01% 1349
2021
Q2
$162K Buy
6,230
+1,065
+21% +$27.7K ﹤0.01% 2076
2021
Q1
$182K Sell
5,165
-107
-2% -$3.77K ﹤0.01% 2092
2020
Q4
$133K Buy
5,272
+1,833
+53% +$46.2K ﹤0.01% 2085
2020
Q3
$130K Sell
3,439
-9,544
-74% -$361K ﹤0.01% 2926
2020
Q2
$556K Buy
12,983
+12,919
+20,186% +$553K 0.02% 925
2020
Q1
$1K Sell
64
-4,152
-98% -$64.9K ﹤0.01% 2719
2019
Q4
$110K Buy
4,216
+1,338
+46% +$34.9K 0.01% 879
2019
Q3
$78K Buy
2,878
+2,804
+3,789% +$76K 0.01% 1498
2019
Q2
$2K Buy
+74
New +$2K ﹤0.01% 3226